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Human papillomavirus (HPV) does not induce lysis of infected keratinocytes, and the exact mechanisms of viral escape are
not known. As keratinocytes differentiate, the cornified cell envelope (CCE) develops, providing a protective barrier to the
host. We previously showed that the normally durable CCE in HPV 11-infected epithelium is fragile compared to CCEs in
healthy epithelium. In this study, we examined uninfected and HPV 11-infected human genital epithelium for expression of
loricrin, the major CCE protein in healthy epidermis. In HPV 11-infected human genital epithelium, detection of loricrin was
reduced in immunoelectron microscopic and immunoblot assays, suggesting that loricrin incorporation into the CCE was
reduced or that loricrin synthesis was reduced. Loricrin detection was reduced in immunohistochemical assays in areas of
high viral replication. Mathematical modeling by least squares was performed using the amino acid composition of highly
purified CCE fragments, confirming that loricrin was markedly reduced and that the small proline-rich proteins and
cytokeratins were increased in those derived from HPV 11-infected epithelium compared to healthy genital epithelium. In
RNase protection and RT-PCR assays, loricrin transcripts were markedly reduced in HPV 11-infected epithelium compared
to uninfected epithelium. Loricrin transcripts were detectable by RNA in situ analysis in isolated cells of HPV 11-infected
epithelium, but were absent in large regions of epithelium. We conclude that HPV 11 infection reduces transcription of the
loricrin gene and that this leads to a reduction in loricrin incorporation into the CCE. Further studies will examine the effectsnd othe
evier SciINTRODUCTION
The keratinocyte is the predominant cell type of
epidermis and is the target of human papillomavirus
(HPV) infection (Eckert et al., 1997). Keratinocytes exit
the cell cycle in the suprabasal layers of epithelium
and undergo the process of differentiation that in-
cludes expression of proteins that become compo-
nents of the cornified cell envelope (CCE) (Rice and
Green, 1977). A dense, covalently linked matrix of
proteins makes up the fully developed CCE (Kubilus
and Baden, 1984; Nemes and Steinert, 1999; Rice and
Green, 1977). The endpoint of differentiation and ke-
ratinization is a layer of flattened, enucleated CCEs
that protect the host against water loss, mechanical
injury, and invasion by microbes.
The CCE is insoluble and can be isolated from
epidermal tissue only by extraction with strong deter-
gents (Jarnik et al., 1998; Robinson et al., 1996; Steinert
and Marekov, 1997; Yaffe et al., 1993). Isolated CCEs
from healthy genital epithelium appear in electron
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240micrographs as dense, 15-nm-thick structures, free of
organelles, with the outline of keratinocytes (Jarnik et
al., 1998). Analysis of CCEs has demonstrated the
presence of loricrin, involucrin, small proline-rich pro-
teins (SPRs), cytokeratin 10, and other proteins co-
valently linked by isopeptide bonds catalyzed by cu-
taneous transglutaminases and by disulfide bonds
(Candi et al., 1995; Marvin et al., 1992; Ming et al.,
1994; Robinson et al., 1997; Steinert et al., 1998; Stein-
ert and Marekov, 1997; Yaffe et al., 1993). Loricrin
contributes 70% of the protein mass to CCEs derived
from healthy genital epithelium (Hohl et al., 1991;
Steven and Steinert, 1994).
Infection of keratinocytes by HPV does not induce
cell lysis, the mechanism used by many viruses to
escape the infected cell. Our prior studies show that
CCEs derived from HPV 11-infected genital epithelium
are thin and fragile compared to those from uninfected
epithelium (Brown and Bryan, 2000). The mechanism
of this cytopathic effect is not known, but could render
the CCE more likely to rupture from mechanical stress,
thus releasing mature virions. In the current study, we
examined the effects of HPV 11 infection on transcrip-of specific HPV gene products on transcription of loricrin a
infected keratinocyte depends on these effects. © 2002 Els
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0042-6822/02 $35.00r CCE components, as it is likely that viral egress from the
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tion and expression of loricrin, the major CCE protein
in healthy epithelium.
RESULTS
Expression of loricrin is altered in HPV 11-infected
genital epithelium
Immunoelectron microscopic analysis (IEM) showed
that loricrin was more abundant in CCE fragments de-
rived from uninfected genital epithelium than in those
from HPV 11-infected genital epithelium (Figs. 1A and
1B). This can be seen by the presence of the larger
15-nm gold beads in Fig. 1A (uninfected tissue) and the
scarcity of large beads in Fig. 1B (HPV 11-infected tis-
sue). Involucrin, represented by the 5-nm gold beads,
remained relatively constant in CCE fragments from un-
infected and infected tissues. Our previous studies
showed that involucrin expression did not change a
great deal in HPV 11-infected epithelium and was there-
fore used as a control in the IEM studies. As we previ-
ously found, fragments derived from HPV-infected epi-
thelium were thinner and smaller (Brown and Bryan,
2000).
Loricrin is normally incorporated into the CCE within
2 h of synthesis in the differentiating keratinocyte (Candi
et al., 1995). Therefore, immunoblots were performed to
determine if reduced loricrin in CCEs was due to de-
creased synthesis of loricrin precursor (Fig. 1C). Extract-
able loricrin (not CCE-incorporated) was detected in pro-
tein extracts from normal, healthy foreskin tissue (Fig.
1C, Lane 1). No loricrin was detected in proteins ex-
tracted from HPV 11-infected human genital epithelium
(Fig. 1C, Lane 2).
Mathematical modeling confirms the reduction in
loricrin in HPV 11 infection
Amino acid analysis was performed on highly purified
CCE fragments derived from healthy genital epithelium
and HPV 11-infected genital epithelium (Table 1). This
analysis showed that glycine and serine were abundant
in highly purified CCE fragments from uninfected epithe-
lium, constituting 36.7 and 21.9%, respectively, of the total
mole percent (mol%) of amino acids. The high percent-
age of glycine plus serine (58.6%) likely reflected the
abundance of these two amino acids in loricrin, the
major CCE protein. Glutamine plus glutamic acid consti-
tuted 7.8% of the total amino acids in CCE fragments from
healthy epithelium; proline was 6.7% of the total mol% of
amino acids.
CCE fragments derived from HPV 11-infected epithe-
lium had a markedly different amino acid profile than
was observed for fragments from uninfected epithelium
(Table 1). The most obvious difference was the reduction
in glycine and serine, constituting 21.4 and 15.7%, re-
spectively (combined 37.1%), of the total mol% of protein.
Glutamine plus glutamic acid were increased to 13.5%
and proline was increased to 12.9% in CCE fragments
derived from HPV 11-infected epithelium.
FIG. 1. IEM and immunoblot analysis to detect loricrin. IEM was performed on CCE fragments derived from uninfected (A) and HPV 11-infected
genital epithelium (B). Loricrin was identified by the presence of the larger 15-nm gold beads (arrows) and involucrin was identified by 5-nm gold
beads (arrowheads). Original magnification, 34,000. (C) Immunoblot analysis to detect loricrin using protein extracts from (Lane 1) uninfected tissue
or (Lane 2) HPV 11-infected tissue. A 30-kDa molecular marker is indicated to the left of the blot.
TABLE 1
Amino Acid Composition (in mol%) of Highly Purified CCE Frag-
ments Derived from Uninfected Human Genital Epithelium (Left Col-
umn) and HPV 11-Infected Human Genital Epithelium (Right Column)
Uninfected tissue HPV 11-infected tissue
Asx 1.6 3.7
Glx 7.8 13.5
Ser 21.9 15.7
Gly 36.7 21.4
His 1.6 2.1
Arg 2.1 3.2
Thr 2.5 3.7
Ala 1.9 3.3
Pro 6.7 12.9
Tyr 2.6 2.9
Val 3.5 4.1
Met 0.2 0.7
Ile 1.5 1.9
Leu 1.4 3.5
Phe 2.6 2.2
Lys 2.9 4.9
Note. Glutamic acid and glutamine were combined in the analysis
(Glx); aspartic acid and asparagine were combined as Asx.
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Mathematical modeling of the amino acid composition
was performed to determine the percentage of the CCE
protein components contained in the covalently linked
matrix (Table 2). Modeling showed that CCE fragments
derived from uninfected genital epithelium were 69.6%
loricrin by mass, a figure very close to prior studies of
CCEs from healthy genital epithelium (Steven and Stein-
ert, 1994). In contrast, loricrin constituted 26% of CCE
fragments derived from HPV 11-infected tissue. SPRs
increased from 12% (uninfected) to 31.2% (HPV 11-infect-
ed), and cytokeratins increased from 4.3% (uninfected) to
23.6% (HPV 11-infected).
Abnormal expression of loricrin occurs in areas of
viral replication
Immunohistochemical analysis showed that abundant
loricrin was detected in the differentiating cells of unin-
fected epithelium (Fig. 2A), but was decreased and
patchy in HPV 11-infected genital epithelium (Fig. 2B).
DNA in situ hybridization was performed to detect HPV
11 sequences in the infected genital epithelium and to
examine the association of HPV infection and abnormal
expression of loricrin (Fig. 2C). This analysis showed that
areas of viral replication correlated with an absence of
detectable loricrin.
HPV 11 infection reduces loricrin transcription
Transcription of loricrin was examined by RNase pro-
tection assays, reverse transcription-polymerase chain
reaction (RT-PCR), and RNA in situ hybridization. The
RNase protection assay showed that a protected frag-
ment of expected size (165 bp) was present in the RNA
derived from uninfected genital epithelium (Fig. 3A, Lane
1), but that only a small amount of protected fragment
was detected in RNA from HPV 11-infected genital epi-
thelium (Fig. 3A, Lane 2). RNA from both uninfected and
infected tissues produced a protected fragment of the
expected size (127 bp) with the -actin probe (Fig. 3A,
Lanes 3 and 4).
The RT-PCR produced a loricrin amplimer of the ex-
pected size (316 bp) using RNA from uninfected genital
epithelium (Fig. 3B, Lane 1). A very faint loricrin amplimer
was detected in RNA from HPV 11-infected genital epi-
thelium (Fig. 3B, Lane 2). RNA from both uninfected and
infected tissues produced an amplimer of the expected
size (400 bp) with the -actin probe (Fig. 3B, Lanes 3
and 4).
The RNA in situ hybridization assay showed that lori-
crin transcripts were present in nearly all suprabasal
cells in healthy genital epithelium (Fig. 4A). In contrast,
loricrin transcripts were detected in a reduced percent-
age of cells in the HPV 11-infected genital epithelium,
being detected in isolated cells, but absent in large
regions of epithelium.
DISCUSSION
A mechanism must exist for HPV to escape the CCE so
that infection can be spread to new hosts. Unlike other
viral infections, such as herpes viruses, HPV infection
does not induce lysis of the target cell. Virion assembly
occurs only in differentiated keratinocytes, cells that
have formed a CCE. It is possible that escape occurs
through pores in the mature CCE, although this seems
unlikely due to the size of mature virions (55 nm in
diameter). A more likely possibility relates to defects in
FIG. 2. Immunohistochemical analysis for detection of loricrin, and
DNA in situ analysis to correlate loricrin to HPV replication. (A) Loricrin
detection in healthy foreskin epithelium. (B) Loricrin detection in HPV
11-infected genital epithelium. (C) HPV 11 detection by DNA in situ
hybridization (adjacent section to that shown in B). Arrows indicate
areas positive for loricrin. Arrowheads indicate areas positive for HPV
11 DNA in B and C. Original magnification, 200.
FIG. 3. RNase protection assay and RT-PCR to analyze loricrin
transcription. (A) RNase protection assay to detect transcripts of loricrin
(Lanes 1 and 2) and -actin (Lanes 3 and 4) in uninfected genital
epithelium (Lanes 1 and 3) and HPV 11-infected genital epithelium
(Lanes 2 and 4). (B) RT-PCR to detect transcripts of loricrin (Lanes 1 and
2) and -actin (Lanes 3 and 4) in uninfected genital epithelium (Lanes
1 and 3) and HPV 11-infected genital epithelium (Lanes 2 and 4).
Molecular markers (in basepairs) are shown to the left of each panel.
FIG. 4. RNA in situ hybridization for detection of loricrin transcripts in
uninfected (A) and HPV 11-infected genital epithelium (B). The approx-
imate position of the basal layer of epithelium is indicated by arrows in
each panel. Original magnification, 400.
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the CCE in HPV 11-infected tissue. In this case, the CCE
is thin and susceptible to mechanical breakage (Brown
and Bryan, 2000). These defects may facilitate the re-
lease of virions once the CCE is deposited on the skin of
the new host.
Admittedly there may be numerous causes of CCE
defects in HPV infection, including alterations in trans-
glutaminases, transcription and/or translation of CCE
gene products, or the lipid barrier of the CCE. In addition,
incorporation of HPV gene products such as E1^E4 may
alter the CCE. In beginning the studies of HPV-induced
alterations of the CCE, we chose to examine the major
CCE component, loricrin.
In addition to immunologic studies, an amino acid
analysis was performed on highly purified CCE frag-
ments, and mathematical modeling was used to com-
pare the composition of fragments from healthy and HPV
11-infected epithelium. Provided that certain conditions
are met, mathematical modeling on the basis of amino
acid composition provides a powerful analytical tool. It
can be used, as we did, to analyze insoluble complexes
made of different proteins such as CCE fragments. The
conditions required for a successful analysis are as
follows: (1) the availability of accurate amino acid com-
positional data; (2) the protein complex should have
relatively few components; (3) the major constituent pro-
teins should be known; and (4) the constituent proteins in
the complex should have individually distinctive amino
acid compositions. These conditions were met in our
analysis.
This modeling approach in general fails to indicate
involucrin in CCEs, although it is likely to be present. In
previous studies using this model, it was estimated that
the threshold for detecting CCE proteins by mathemati-
cal modeling is approximately 3% or possibly slightly
higher depending on the amino acid composition of the
protein (Jarnik et al., 1996). In any case, we do not
consider any modeling-based estimates under 5% very
credible. This sensitivity may not be sufficient to reveal
involucrin, a CCE protein that is usually present in only
small amounts. The same explanation applies to several
other CCE proteins known to be present in small
amounts, such as cystatin- and elafin.
We previously showed that detection of the HPV 11
E1^E4 protein and that of loricrin are mutually exclusive.
The E1^E4 protein is produced in areas of high viral
replication and appears to associate with the CCE (Bryan
et al., 2000). Although not indicated in Table 2, an addi-
tional mathematical modeling was performed consider-
ing the possibility of the E1^E4 protein as a CCE com-
ponent, and the result consistently showed that 5 to 6%
of the CCE mass was due to E1^E4. Further studies are
being performed to verify this observation. Therefore, it is
not yet clear if E1^E4 has a role in altering the CCE or
simply serves as a marker for intense viral replication.
Other viral gene products may be responsible for CCE
abnormalities.
Our studies indicate that expression of the loricrin
gene is reduced in areas of HPV 11 replication. CCEs
from healthy human genital epithelium are approximately
65 to 70% loricrin (Steven and Steinert, 1994), and the
thinner wall of the CCE from HPV 11-infected epithelium
may be due to reduced expression of this protein, which
was only 26% of the CCE mass. The mechanism causing
these abnormalities appears to involve alterations in
transcription. We believe that HPV proteins that are ex-
pressed early and are known to regulate gene transcrip-
tion are likely to have a role in this process.
Cytokeratins and SPR proteins were both increased in
CCEs from HPV-infected tissue. Cytokeratins normally
are minor components of CCEs from healthy epithelium,
and our results are consistent with this (Steven and
Steinert, 1994). We recently found that cytokeratin 16, a
protein not normally expressed in healthy epithelium, is
expressed in abundance in HPV 11-infected genital ep-
ithelium (McClowry et al., 2002). The effects of increased
cytokeratins and SPRs on the CCE are not yet known.
In summary, loricrin incorporation into the CCE and
detection of extractable loricrin were reduced in HPV
11-infected genital epithelium. Increased viral replication
correlated with the reduction of loricrin detection. CCEs
derived from HPV 11-infected epithelial tissue were com-
positionally different from those derived from uninfected
epithelium, containing a markedly reduced percentage of
loricrin, the major CCE protein. Loricrin transcripts were
reduced in HPV 11-infected epithelium, accounting for
TABLE 2
Modeled Mass Fractions (%) of Cell Envelope Proteins
Filaggrin Cytokeratins Loricrin SPRs Sum
Uninfected 15.5 1.4 4.3 1.4 69.6 0.7 12.0 0.5 101.5 4.0
HPV 11-infected 15.9 0.5 23.6 1.6 26.2 0.8 31.2 0.5 102.5 4.3
Note. The protein compositional analysis was based on seven proteins known to be present in human CCEs, including filaggrin, cytokeratins,
loricrin, SPRs, involucrin, elafin, and cystatin-. Proteins that initially showed “negative” amounts were removed from the next analysis, as they
individually represented a small percentage of the overall total protein mass. The calculation was repeated until all values were positive. Uninfected:
analysis of highly purified CCE fragments from uninfected epithelium (foreskin tissue). HPV 11-infected: analysis of CCE fragments from HPV
11-infected epithelium (condylomata acuminata lesions).
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the diminished detection of loricrin protein. This reduc-
tion of loricrin could contribute to the thin, fragile CCEs
found in HPV 11 infection. Further studies will examine
the effects of specific HPV gene products on the CCE.
MATERIALS AND METHODS
Preparation of CCE fragments
Human foreskin tissue and condylomata acuminata
lesions were used to prepare intact CCEs. Foreskin tis-
sues, four in all, were acquired from routine circumci-
sions, totaling approximately 1 g of tissue. Four condy-
lomata acuminata lesions of external genitalia were ac-
quired from excision biopsies, totaling approximately 500
mg of tissue. DNA was extracted as previously described
from a small fragment (approximately 20 mg) of each
condylomata acuminata lesion. A PCR/reverse blot strip
assay was performed as previously described to confirm
the presence of HPV 11 in each lesion (Gravitt et al.,
2000).
Tissue to be used for preparation of CCEs was minced
and then heated to 100°C for 60 min in 2% extraction
buffer (2% EB) containing 50 mM Tris–HCl, pH 7.4, 2%
SDS, 130 mM -mercaptoethanol, and 10 mM DDT. Fol-
lowing centrifugation at 4000g for 15 min at room tem-
perature, the supernate was removed and discarded.
The pellet was extracted two more times as above,
except that 0.2% SDS was used as the extraction buffer
(0.2% EB). The pellet was suspended in 1 ml of 0.2% EB
and then layered onto a 3% Ficoll cushion in 0.2% EB.
Following centrifugation at 800g for 10 min, a white band
was visible in the center of the Ficoll gradient. The band
was removed and diluted to 10 ml in 0.2% EB. CCEs were
pelleted by centrifugation at 4000g for 10 min. The pres-
ence of intact CCEs was confirmed by phase-contrast
microscopy.
CCE fragments were prepared by sonication of intact
CCEs in 0.2% EB. A Fisher Sonic Dismembrator (Model
300) with the intermediate size tip was used at a setting
60% of maximum output for 2 min. Phase-contrast mi-
croscopy was performed to document the absence of
intact CCEs in the preparations. Repeat extraction was
performed on the CCE fragments at 100°C for 60 min in
2% EB, followed by repeat extraction in 0.2% EB. CCE
fragments were pelleted at 5000g and then resuspended
in 1 ml of 0.2% EB. Electron microscopy of CCE fragment
preparations was performed as previously described to
ensure complete fragmentation (Bryan and Brown, 2000).
Immunoelectron microscopy
CCE fragments were pelleted and resuspended in 1
Diluent-Blocker solution (Kirkgaard and Perry, Gaithers-
burg, MD) for 1 h at 4°C on a rocker. CCE fragments
were pelleted and washed three times with phosphate-
buffered saline, pH 7.4, plus 0.01% Tween 20 (PBS-T).
Anti-loricrin rabbit serum was purchased from Berkley
Antibody Co. (Richmond, CA). Anti-involucrin monoclonal
mouse antibodies were purchased from Novacastra
(Newcastle upon Tyne, UK). Primary antibodies were
added at 1:500 dilutions in PBS-T for 24 h at 4°C. CCE
fragments were washed three times in PBS-T, and then
secondary antibodies were added. Secondary antibod-
ies were goat anti-rabbit (labeled with gold beads, 15
nm) and goat anti-mouse (labeled with gold beads, 5 nm)
(Amersham Pharmacia Biotech, Inc., Piscataway, NJ).
Secondary antibodies were incubated at 1:75 dilution
with CCE fragments for 24 h at 4°C, and unbound anti-
bodies were removed by washing three times in PBS-T.
Each CCE preparation was pelleted by centrifugation,
and the pellet was fixed in 3% gluteraldehyde. The CCE
pellets were then embedded and sectioned. Sections
were stained with uranyl acetate and examined by trans-
mission electron microscopy.
Immunoblot detection of loricrin
Human genital epithelium from HPV 11-infected and
uninfected tissue was pulverized and boiled in TSB ex-
traction buffer (10 mM Tris–HCl, 5% SDS, and 20% -mer-
captoethanol) for 10 min at 100°C. Samples were centri-
fuged at 10,000g for 20 min and the supernatant contain-
ing insoluble proteins was removed. These extracts were
diluted 1:1 in Laemmli buffer and the resulting suspen-
sions were heated to 100°C for 10 min and centrifuged at
10,000g for 2 min. Proteins were quantified using the RC
DC Protein Assay (Bio-Rad Laboratories, Hercules, CA)
and equal amounts of protein were separated on a 15%
SDS–PAGE gel. Proteins were transferred to a nitrocel-
lulose membrane (Protran, Midwest Scientific, Valley
Park, MO) with a Mini Trans-Blot cell (Bio-Rad Laborato-
ries). Membranes were blocked for 1 h in TBS-T blocking
diluent (50 mM Tris–HCl, pH 7.4, 150 mM NaCl, 0.1%
Tween 20) and anti-loricrin antibody was added at a
1:1000 dilution overnight. Membranes were washed
three times (5 min each) in TBS-T and secondary anti-
rabbit antibodies conjugated to horseradish peroxidase
(Kirkegaard and Perry Laboratories, Gaithersburg, MD)
were added at a 1:50,000 dilution in TBS-T  2.5% nonfat
dry milk for 1 h. Membranes were washed as described
above and antibody binding was visualized using the
chemiluminescent SuperSignal Substrate detection sys-
tem (Pierce, Rockford, IL).
Amino acid analysis and modeled amino acid
composition
Acid hydrolysis of CCE fragments was performed fol-
lowed by amino acid analysis. Aliquots of purified CCE
fragments from uninfected and HPV 11-infected genital
epithelium were hydrolyzed in 6 N HCl for 22 h at 110°C.
After hydrolysis, the samples were dried in a Speedvac
(Savant Instruments, Farmingdale, NY) and then derivat-
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ized using the AccQ-Taq Chemistry Package (Millipore
Corp., Bedford, MA). Derivatized samples were analyzed
on a Beckman 126 Pump System (Beckman Instruments,
Palo Alto, CA), using a Beckman 166 Detector and 507
Autosampler. The column employed was an AccQ-Taq
Amino Acid Analysis Column (Millipore). The amino acid
composition of each sample was expressed in mol%.
The modeled amino acid composition was fitted to the
experimental data by least squares, as previously de-
scribed (Jarnik et al., 1996; Steven and Steinert, 1994).
This analysis uses the known amino acid composition of
proteins known to constitute nearly 100% of the protein
mass, such as in the case of the CCE (Kapp et al., 1990).
The model was applied to determine the percentage of
each protein in the CCE samples from healthy epithelium
(human foreskin) or HPV 11-infected epithelium (condy-
lomata acuminata tissue). The program was run on a
DEC Alpha 3000–5000 workstation (Digital). Tryptophan
and cysteine were omitted from the analysis. The quality
of the fits was assessed by (1) median discrepancy
(absolute value) and (2) root-mean-square discrepancy.
The errors in the compositional values were estimated
by adding a random error in the interval of 0.4%/0.4%
to each amino acid in the experimentally determined
composition of the purified CCE fragments under con-
sideration and then observing the resulting changes in
calculated protein composition. The error values repre-
sented averages of 1000 trials.
Immunohistochemical detection of loricrin
Sections of uninfected and HPV 11-infected human
genital epithelial tissue were deparaffinized in xylene
and ethanol and then treated with 3% H2O2 in methanol
to reduce endogenous peroxidase activity. Anti-loricrin
antibody was added at a 1:500 dilution for 24 h at room
temperature in a humidity chamber. Antibody binding
was detected using the Vectastain ABC detection system
(Vector Laboratories, Burlingame, CA) followed by stain-
ing with the Vector VIP peroxidase substrate, to yield a
purple precipitate.
DNA in situ detection of HPV 11
Paraffin-embedded tissue sections of HPV 11-infected
human genital epithelium were fixed by heating at 80°C
for 15 min. Sections were then deparaffinized in xylene
followed by ethanol. Sections were then treated with 25
g/ml proteinase K for 5 min at 37°C followed by 3%
H2O2 in methanol for 30 min. Sections were washed in
PBS, dehydrated by incubation in ethanol, and dried at
37°C. A biotinylated HPV 11 DNA probe (Enzo) was
added at 5 ng/l. Sections were covered with a HybriSlip
(Research Products International, Mount Prospect, IL)
and heated at 95°C for 10 min. Probe DNA and target
DNA were allowed to hybridize overnight at 37°C in a
humidity chamber. Sections were washed in 20% form-
amide in 2 SSC plus 0.05% Tween 20 for 10 min at
37°C, followed by an additional wash in 2 SSC plus
0.05% Tween 20 for 10 min at 37°C. Sections were
blocked and probes were detected using the Tyramide
Signal Amplification Cyanine 3 System (NEN Life Sci-
ences, Boston, MA). Sections were dehydrated in etha-
nol and mounted using Vectashield (Vector Laborato-
ries). Slides were inspected using a fluorescence micro-
scope at 590-nm wavelength.
RNase protection assay (RPA)
The entire human loricrin gene was amplified from a
cDNA library of human foreskin tissue and cloned into
pCR3.1 (Brown et al., unpublished results). The 3 region
(316 bp) was amplified using the same primers as below
for RT-PCR and subcloned in the sense direction into
pCRII-TOPO, which contains the T7 promoter at the 3
end of the multiple cloning site. To generate a template
for in vitro transcription, the most 3 165 bp of loricrin and
the downstream T7 promoter were amplified using the
following primers: forward 5ATTGGCAGCGGCTGCAT-
CAT; reverse 5GTTTTCCCAGTCACGACGTT (in the M13
region of the pCRII-TOPO vector). As a control, a linear-
ized plasmid encoding human -actin was used (pTRI-
actin-125, Ambion).
Biotinylated probes were synthesized with a MAXI-
script Kit (Ambion) using biotin-16–UTP (Enzo Diagnos-
tics, Farmingdale, NY). Total RNA was isolated from HPV-
infected and uninfected tissues as described below and
RPA was performed with the RPAIII kit (Ambion). RPA
products were separated on a 10% polyacrylamide/
TBE/8 M urea gel (Bio-Rad Laboratories), transferred to a
BrightStar positively charged nylon membrane (Ambion)
using the Panther semidry electroblotter (OWL Separator
Systems, Portsmouth, NH), and UV cross-linked using
the UV Stratalinker 1800 (Stratagene, La Jolla, CA). Biotin-
labeled RNA probes were detected using the chemilu-
minescent BrightStar Biodetect System (Ambion, Austin,
TX).
RT-PCR analysis
Loricrin transcription was analyzed by RT-PCR using
the Titan One-Tube RT-PCR System (Roche Molecular
Diagnostics, Indianapolis, IN). Total RNA was extracted
from human foreskin tissue and a large HPV 11-infected
condyloma acuminata lesion using the RNaqueous Midi
System (Ambion) according to the manufacturer’s proto-
col. RNA was treated with DNA-free (Ambion) to elimi-
nate contaminating DNA. RT-PCR was performed on 100
ng total RNA. Primers were used for loricrin spanning 316
bp at the 3 end of the mRNA coding sequence. To verify
the integrity of the RNA samples, human -actin primers
were also used for each total RNA sample. The primers
and PCR conditions were as follows: loricrin (forward)
5ACGTCTCCTCGCAGCAGG, (reverse) 5CTATTTGGAC-
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GGCCAGGT; -actin (forward) 5ATGTACGTTGCTATCC-
AGGC, (reverse) 5CGCTCATTGCCAATGGTGAT. Reverse
transcription was performed at 55°C for 30 min. Thermal
cycling parameters were as follows: 94°C for 1 min,
56°C for 1 min, 68°C for 1 min for a total of 30 cycles,
followed by a 6-min incubation at 68°C. The PCR prod-
ucts were electrophoresed on a 1.5% agarose gel and
visualized by ethidium bromide staining.
RNA in situ hybridization
Paraffin-embedded tissue sections were fixed by heat-
ing at 60°C for 30 min. Sections were deparaffinized by
incubation in xylene followed by a series of ethanol
incubations and dried at 37°C. Slides were next treated
with 0.05% pepsin in 0.2 M HCl for 20 min and then fixed
with 4% paraformaldehyde in PBS for 10 min. Sections
were equilibrated in 0.1 M triethanolamine for 2 min
followed by acetylation in 0.25% acetic anhydride in 0.1 M
triethanolamine for 10 min. Next, sections were treated
with 3% H2O2 in methanol for 30 min. Sections were
washed twice in PBS for 5 min after each treatment.
Sections were dehydrated by incubation in ethanol and
dried at 37°C before addition of probe.
An oligonucleotide probe for loricrin was designed con-
taining four biotinylated dTTPs at the 3 end (Hougaard
et al., 1997). The loricrin probe sequence was CTGAGG-
GGTGGGCTGCTTTTTCTGATAAGACT*CT*CT*CT*C (each
biotin molecule is indicated by an asterisk) and was syn-
thesized by New England Biolabs (Beverly, MA). Probes
were added at 40 ng/l in hybridization solution [50% for-
mamide, 2 SSC, 1 Denhardt’s solution, 10% dextran
sulfate, 0.5 mg/ml yeast tRNA (Sigma, St. Louis, MO), and
0.5 mg/ml salmon sperm DNA (Sigma)], covered with a
HybriSlip (Research Products International), and allowed to
hybridize overnight at 37°C in a humidity chamber.
After hybridization, sections were washed twice in 2
SSC for 15 min at 42°C, followed by two additional
washes in 0.2 SSC at 42°C. Sections were blocked and
probes were detected using the Tyramide Signal Ampli-
fication Cyanine 3 System (NEN Life Science Products)
as follows. Sections were blocked in TNB Blocking Buffer
[0.1 M Tris–HCl, pH 7.4, 0.15 M NaCl, 0.5% Blocking
Reagent (supplied in kit)] for 30 min at room temperature
followed by addition of the streptavidin–HRP conjugate
diluted at 1:100 in TNB. Sections were washed three
times for 5 min in TNT wash buffer (0.1 M Tris–HCl, pH
7.4, 0.15 M NaCl, 0.05% Tween 20) and the Cyanine 3
Tyramide reagent was added at a 1:50 dilution in ampli-
fication diluent (supplied in kit) for 20 min. Sections were
washed in TNT wash buffer as described, dehydrated in
a series of ethanol washes, and mounted using Vecta-
shield mounting medium (Vector Laboratories). Slides
were inspected using a fluorescence microscope at
590-nm wavelength.
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